• Consensus Rating: Moderate Buy
  • Consensus Price Target: $10.00
  • Forecasted Upside: 170.27%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.70
▼ -0.03 (-0.80%)

This chart shows the closing price for SURG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SurgePays Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SURG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SURG

Analyst Price Target is $10.00
▲ +170.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for SurgePays in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 170.27% upside from the last price of $3.70.

This chart shows the closing price for SURG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 investment analysts is to moderate buy stock in SurgePays. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/1/2024Ascendiant Capital MarketsLower TargetBuy ➝ Buy$11.50 ➝ $10.00Low
3/13/2024Maxim GroupDowngradeBuy ➝ HoldLow
12/1/2022Maxim GroupBoost Target$10.00 ➝ $15.00Low
9/6/2022Ascendiant Capital MarketsBoost Target$8.75Low
3/28/2022Maxim GroupBoost Target$6.00 ➝ $8.00High
2/28/2022Maxim GroupInitiated CoverageBuy$6.00High
1/24/2022Ascendiant Capital MarketsInitiated CoverageBuy$7.00Medium
(Data available from 4/21/2019 forward)

News Sentiment Rating

0.55 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/23/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 8 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/21/2024
  • 8 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/22/2024
  • 5 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/21/2024

Current Sentiment

  • 5 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
SurgePays logo
SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.
Read More

Today's Range

Now: $3.70
Low: $3.66
High: $3.80

50 Day Range

MA: $5.57
Low: $3.66
High: $8.97

52 Week Range

Now: $3.70
Low: $3.64
High: $9.23

Volume

182,493 shs

Average Volume

350,147 shs

Market Capitalization

$71.37 million

P/E Ratio

2.66

Dividend Yield

N/A

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of SurgePays?

The following equities research analysts have issued stock ratings on SurgePays in the last year: Ascendiant Capital Markets, Maxim Group, and TheStreet.
View the latest analyst ratings for SURG.

What is the current price target for SurgePays?

1 Wall Street analysts have set twelve-month price targets for SurgePays in the last year. Their average twelve-month price target is $10.00, suggesting a possible upside of 170.3%. Ascendiant Capital Markets has the highest price target set, predicting SURG will reach $10.00 in the next twelve months. Ascendiant Capital Markets has the lowest price target set, forecasting a price of $10.00 for SurgePays in the next year.
View the latest price targets for SURG.

What is the current consensus analyst rating for SurgePays?

SurgePays currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SURG.

What other companies compete with SurgePays?

How do I contact SurgePays' investor relations team?

SurgePays' physical mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The medical equipment provider's listed phone number is (901) 302-9587 and its investor relations email address is [email protected]. The official website for SurgePays is www.surgeholdings.com. Learn More about contacing SurgePays investor relations.